卑詩研究中心與華合作 續研發愛滋病治療

綜合報道
卑詩愛滋病/愛滋病毒卓越研究中心(BC Centre for Excellence in HIV/AIDS)與中國疾病控制與預防中心(Chinese Centre for Disease Control and Prevention),再次簽署協議,共同研究和改良愛滋病治療方法,中國疾控中心將繼續推廣使用由卑詩省研發的「治療如同預防」(Treatment as Prevention)的對抗愛滋病方法。
愛滋病卓越研究中心總監蒙塔納(Julio Montaner)透露,雙方正式簽署新一份諒解備忘錄,未來3年內,中國將會派出3個專家到卑詩省共同進行研究工作。
卑詩省與中國醫療機構的愛滋病研究合作關係早於2009年開始。直至2011年,中國疾控中心正式宣布,採用由卑詩省研發的「治療如同預防」愛滋病治療方法,成為全球首個採納這個方法作為全國對抗愛滋病政策的國家。
至2013年11月,中國疾控中心與卑詩省簽署首份諒解備忘錄,建立為期3年的愛滋病研究合作項目,中方每年派出專家到來本省學習及共同研究。

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below